These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10730323)

  • 21. MRS of normal and impaired fetal brain development.
    Girard N; Fogliarini C; Viola A; Confort-Gouny S; Fur YL; Viout P; Chapon F; Levrier O; Cozzone P
    Eur J Radiol; 2006 Feb; 57(2):217-25. PubMed ID: 16387464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance spectroscopy in cognitive research.
    Ross AJ; Sachdev PS
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):83-102. PubMed ID: 15003387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased prefrontal Myo-inositol in major depressive disorder.
    Coupland NJ; Ogilvie CJ; Hegadoren KM; Seres P; Hanstock CC; Allen PS
    Biol Psychiatry; 2005 Jun; 57(12):1526-34. PubMed ID: 15953489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
    Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR spectroscopy in multiple sclerosis.
    De Stefano N; Filippi M
    J Neuroimaging; 2007 Apr; 17 Suppl 1():31S-35S. PubMed ID: 17425732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1H magnetic resonance spectroscopy in multiple sclerosis and related disorders.
    Rovira A; Alonso J
    Neuroimaging Clin N Am; 2013 Aug; 23(3):459-74. PubMed ID: 23928200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
    Falini A; Bozzali M; Magnani G; Pero G; Gambini A; Benedetti B; Mossini R; Franceschi M; Comi G; Scotti G; Filippi M
    Neuroimage; 2005 Jul; 26(4):1159-63. PubMed ID: 15878675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.
    Stork C; Renshaw PF
    Mol Psychiatry; 2005 Oct; 10(10):900-19. PubMed ID: 16027739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of degenerative brain disorders.
    Berson BD
    Curr Opin Radiol; 1991 Feb; 3(1):51-4. PubMed ID: 2025508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [First and second generation antipsychotics and morphological and neurochemical brain changes in schizophrenia. Review of magnetic resonance imaging and proton spectroscopy findings].
    Szulc A
    Psychiatr Pol; 2007; 41(3):329-38. PubMed ID: 17900049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain MRI and proton MRS findings in infants and children with respiratory chain defects.
    Dinopoulos A; Cecil KM; Schapiro MB; Papadimitriou A; Hadjigeorgiou GM; Wong B; deGrauw T; Egelhoff JC
    Neuropediatrics; 2005 Oct; 36(5):290-301. PubMed ID: 16217703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
    Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases.
    Mason GF; Krystal JH
    NMR Biomed; 2006 Oct; 19(6):690-701. PubMed ID: 16986118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M
    Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance spectroscopic methods for the assessment of metabolic functions in the diseased brain.
    Hall H; Cuellar-Baena S; Dahlberg C; In't Zandt R; Denisov V; Kirik D
    Curr Top Behav Neurosci; 2012; 11():169-98. PubMed ID: 22076698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors].
    Galanaud D; Nicoli F; Le Fur Y; Roche P; Confort-Gouny S; Dufour H; Ranjeva JP; Peragut JC; Viout P; Cozzone PJ
    Ann Med Interne (Paris); 2002 Dec; 153(8):491-8. PubMed ID: 12610422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton MR spectroscopy of the brain.
    Rand SD; Prost R; Li SJ
    Neuroimaging Clin N Am; 1999 May; 9(2):379-95. PubMed ID: 10318721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.